Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-024925
Date:2021-02-15
Issuer: INTERCEPT PHARMACEUTICALS, INC. (ICPT)
Original Submission Date:

Reporting Person:

RICHARDSON LINDA M
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37 NEW YORK, NY 10001

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-15 A 5,531 a $0.00 26,866 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION TO PURCHASE COMMON STOCK 31.32 2021-02-15 deemed execution date A 8,500 (a) 2031-02-15 common stock 8,500 $31.32 8,500 direct
Footnotes
IDfootnote
f1 represents restricted stock units granted to the reporting person. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. the award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the vesting commencement date. the vesting commencement date is february 15, 2021.
f2 the award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the vesting commencement date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. the vesting commencement date is february 15, 2021.
WhaleWisdom Logo

Elevate your investments